{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:34:33Z","timestamp":1793169273497,"version":"4.5.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"37","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Zhejiang Medical and Health Science and Technology project","award":["2022KY001"],"award-info":[{"award-number":["2022KY001"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9,11]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      This study evaluates the association between prophylactic heparin use and mortality in intensive care unit (ICU) patients with acute respiratory failure (ARF). A retrospective cohort study was conducted using the Medical Information Mart for Intensive Care IV database. Adult ICU patients diagnosed with ARF were included. Patients receiving subcutaneous unfractionated heparin (5000 units) within 72 hours of ICU admission were compared with non-recipients. Propensity score matching was used to balance baseline characteristics. The primary outcome was 28-day all-cause mortality; secondary outcomes included in-hospital mortality and length of stay. Of 880 eligible patients, 703 received heparin and 177 did not. After 1:1 propensity score matching, 256 patients were analyzed (128 per group). Heparin use was associated with significantly lower 28-day all-cause mortality (32.03% vs 52.34%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.002) and in-hospital mortality (28.12% vs 46.88%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.003). Multivariable Cox regression confirmed reduced mortality risks (28-day hazard ratio\u2005=\u20050.46, 95% confidence interval: 0.30\u20130.69; in-hospital hazard ratio\u2005=\u20050.45, 95% confidence interval: 0.29\u20130.70). Subgroup analyses consistently supported these findings. However, heparin use was associated with longer ICU and hospital length of stay. Early prophylactic heparin administration is independently associated with reduced short-term mortality in ICU patients with ARF, supporting its potential role in comprehensive ARF management.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050678","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:09:10Z","timestamp":1789142950000},"page":"e50678","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Prophylactic heparin and mortality in patients with acute respiratory failure in the ICU"],"prefix":"10.1097","volume":"105","author":[{"given":"Saichan","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Critical Care Medicine, Quzhou Kecheng People\u2019s Hospital, Quzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchao","family":"Mao","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Zhejiang Hospital, Hangzhou, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changqin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Zhejiang Hospital, Hangzhou, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyun","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Zhejiang Hospital, Hangzhou, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8005-0860","authenticated-orcid":false,"given":"Minjia","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Zhejiang Hospital, Hangzhou, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261028","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1213\/01.ane.0000237433.00877.5a","article-title":"Initial and delayed onset of acute respiratory failure: factors associated with development and outcome.","volume":"103","author":"Lobo","year":"2006","journal-title":"Anesth Analg"},{"key":"R2-20261028","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1001\/jama.2016.0291","article-title":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries.","volume":"315","author":"Bellani","year":"2016","journal-title":"JAMA"},{"key":"R3-20261028","first-page":"2526","article-title":"Acute respiratory distress syndrome: the Berlin Definition.","volume":"307","author":"Ranieri","year":"2012","journal-title":"JAMA"},{"key":"R4-20261028","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0140-6736(22)01485-4","article-title":"Acute respiratory distress syndrome: causes, pathophysiology, and phenotypes.","volume":"400","author":"Bos","year":"2022","journal-title":"Lancet"},{"key":"R6-20261028","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","article-title":"High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.","volume":"46","author":"Helms","year":"2020","journal-title":"Intensive Care Med"},{"key":"R7-20261028","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12871-021-01545-w","article-title":"Unfractionated heparin improves the clinical efficacy in adult sepsis patients: a systematic review and meta-analysis.","volume":"22","author":"Fu","year":"2022","journal-title":"BMC Anesthesiol"},{"key":"R8-20261028","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1111\/jth.13555","article-title":"A century of heparin: past, present and future.","volume":"14","author":"Hemker","year":"2016","journal-title":"J Thromb Haemost"},{"key":"R10-20261028","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S2213-2600(20)30470-7","article-title":"Nebulised heparin for patients with or at risk of acute respiratory distress syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial.","volume":"9","author":"Dixon","year":"2021","journal-title":"Lancet Respir Med"},{"key":"R11-20261028","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1056\/NEJM200209263471316","article-title":"Low-dose heparin for severe sepsis.","volume":"347","author":"Davidson","year":"2002","journal-title":"N Engl J Med"},{"key":"R12-20261028","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa2103417","article-title":"Therapeutic anticoagulation with heparin in critically Ill patients with Covid-19.","volume":"385","author":"Goligher","year":"2021","journal-title":"N Engl J Med"},{"key":"R13-20261028","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1182\/blood.2021014527","article-title":"Anticoagulation in hospitalized patients with COVID-19.","volume":"140","author":"Baumann Kreuziger","year":"2022","journal-title":"Blood"},{"key":"R14-20261028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41597-022-01899-x","article-title":"MIMIC-IV, a freely accessible electronic health record dataset.","volume":"10","author":"Johnson","year":"2023","journal-title":"Sci Data"},{"key":"R15-20261028","doi-asserted-by":"crossref","first-page":"e296","DOI":"10.1371\/journal.pmed.0040296","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"4","author":"von Elm","year":"2007","journal-title":"PLoS Med"},{"issue":"4 Suppl","key":"R16-20261028","doi-asserted-by":"crossref","first-page":"S296","DOI":"10.1097\/01.CCM.0000057906.89552.8F","article-title":"Epidemiology and outcome of acute respiratory failure in intensive care unit patients.","volume":"31","author":"Vincent","year":"2003","journal-title":"Crit Care Med"},{"key":"R17-20261028","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.arthro.2021.06.037","article-title":"Best practice guidelines for propensity score methods in medical research: consideration on theory, implementation, and reporting. A review.","volume":"38","author":"Chen","year":"2022","journal-title":"Arthroscopy"},{"key":"R18-20261028","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1161\/CIRCOUTCOMES.109.875658","article-title":"Missing data analysis using multiple imputation: getting to the heart of the matter.","volume":"3","author":"He","year":"2010","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"R19-20261028","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40560-024-00723-5","article-title":"Exploring the therapeutic role of early heparin administration in ARDS management: a MIMIC-IV database analysis.","volume":"12","author":"Xiao","year":"2024","journal-title":"J Intensive Care"},{"key":"R20-20261028","doi-asserted-by":"crossref","first-page":"44","DOI":"10.36469\/jheor.001c.92408","article-title":"Effectiveness, safety, and costs of thromboprophylaxis with enoxaparin or unfractionated heparin among medical inpatients with chronic obstructive pulmonary disease or heart failure.","volume":"11","author":"Amin","year":"2024","journal-title":"J Health Econ Outcomes Res"},{"key":"R21-20261028","doi-asserted-by":"crossref","first-page":"1076029619887437","DOI":"10.1177\/1076029619887437","article-title":"Acute respiratory distress syndrome as an organ phenotype of vascular microthrombotic disease: based on hemostatic theory and endothelial molecular pathogenesis.","volume":"25","author":"Chang","year":"2019","journal-title":"Clin Appl Thromb Hemost"},{"key":"R22-20261028","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.thromres.2020.08.026","article-title":"Extensive pulmonary perfusion defects compatible with microthrombosis and thromboembolic disease in severe Covid-19 pneumonia.","volume":"196","author":"Beenen","year":"2020","journal-title":"Thromb Res"},{"key":"R24-20261028","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.jtha.2025.01.009","article-title":"Basics of diagnosis and treatment of venous thromboembolism.","volume":"23","author":"Cox","year":"2025","journal-title":"J Thromb Haemost"},{"key":"R25-20261028","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12959-023-00572-6","article-title":"Association between antithrombotic therapy and mortality in patients hospitalized for COVID\u201119.","volume":"22","author":"Wang","year":"2024","journal-title":"Thromb J"},{"key":"R26-20261028","doi-asserted-by":"crossref","first-page":"1537994","DOI":"10.3389\/fphar.2025.1537994","article-title":"Aspirin is associated with a reduction in mortality rate for patients with sepsis-induced coagulopathy: a retrospective cohort study.","volume":"16","author":"Xu","year":"2025","journal-title":"Front Pharmacol"},{"key":"R27-20261028","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/cei.13480","article-title":"Heparin affects the induction of regulatory T cells independent of anti-coagulant activity and suppresses allogeneic immune responses.","volume":"202","author":"Kashiwakura","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"R28-20261028","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10557-021-07251-6","article-title":"Low molecular weight heparin, anti-inflammatory\/immunoregulatory and antiviral effects, a short update.","volume":"37","author":"Vitiello","year":"2023","journal-title":"Cardiovasc Drugs Ther"},{"key":"R29-20261028","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.phrs.2016.08.008","article-title":"Low molecular weight heparins prevent the induction of autophagy of activated neutrophils and the formation of neutrophil extracellular traps.","volume":"123","author":"Manfredi","year":"2017","journal-title":"Pharmacol Res"},{"key":"R30-20261028","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/intimm\/dxz084","article-title":"Heparin induces neutrophil elastase-dependent vital and lytic NET formation.","volume":"32","author":"Lelliott","year":"2020","journal-title":"Int Immunol"},{"key":"R31-20261028","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/s41467-019-09160-7","article-title":"Neutrophil activation and NETosis are the major drivers of thrombosis in heparin-induced thrombocytopenia.","volume":"10","author":"Perdomo","year":"2019","journal-title":"Nat Commun"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050678","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:01:24Z","timestamp":1793167284000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050678"}},"subtitle":["A retrospective cohort study based on the MIMIC-IV database"],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":28,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050678","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"assertion":[{"value":"2026-02-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}